CClinicalTrials.gg
Not yet recruitingNCT07508696CERBERUSUpdated Apr 2, 2026

Cerebellar Research in Ultrasound Stimulation

An interventional study of Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox and Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox in Essential Tremor, sponsored by KU Leuven. Not yet recruiting at 1 site in Belgium. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by KU Leuven · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Experiment 1: Modulation of Physiological Tremor in Healthy Volunteers Thirty healthy volunteers will undergo TUS targeting the dentate nucleus in a randomized, double-blinded crossover design. Tremor amplitude, induced by a 15 g weight, will be measured using an accelerometer, and EEG will assess neural oscillations and cerebello-thalamo-cortical connectivity.

Stimulation will include short-term (1 minute on/off for 12 minutes) and long-term (30 minutes) protocols, as well as closed-loop TUS for phase-specific effects. This experiment aims to optimize stimulation parameters and explore the dentate nucleus's role in tremor generation.

Experiment 2: Tremor Modulation in Essential Tremor Patients Thirty ET patients will receive TUS targeting the dentate nucleus with optimized parameters from Experiment 1 in a randomized crossover design. The best protocol from previous experiment will be tested here. Tremor amplitude and EEG will be recorded to assess short- and long-term effects of TUS on pathological tremor.

Read the detailed description

Experiment 1: Modulation of Physiological Tremor in Healthy Volunteers This is a randomized, double-blinded, crossover study involving 30 healthy volunteers. Healthy volunteers will be recruited from campus with a flyer and using social media platforms. Each participant will undergo two conditions: on-target transcranial focused ultrasound stimulation (TUS) to the dentate nucleus and off-target (sham) stimulation. Initial screening will be performed via phone, after which an informed consent will be signed. The full experiment will consist of four separate visit days, of which only the first one will take place at the UZ Leuven department of Radiology. Visit days 2-4 will entirely be performed at the KU Leuven Brainshub facility in gebouw De Nayer.

  • Visit 1: Imaging On the first visit, participants will undergo MRI scans to obtain structural (T1-weighted) and Ultrashort Echo Time (UTE) MRI images. These scans will help reconstruct individual head models to estimate skull characteristics and optimize the TUS target engagement. Using the MRI data, simulations will be performed to calculate the optimal position, shape, size, and pressure of the ultrasound beam. This ensures precise targeting of the dentate nucleus on an individual level during subsequent stimulation sessions.
  • Visit 2: Immediate effects on Tremor Modulation and Phase Entrainment During this visit, participants will perform a task to induce physiological tremor (e.g., holding a weight on their finger). Tremor amplitude will be measured using an accelerometer. TUS will be applied in two conditions: on-target stimulation to the dentate nucleus and off-target sham stimulation. The stimulation will follow a short-term protocol (1 minute on, 1 minute off, repeated for 12 minutes). EEG will be recorded to assess changes in neural oscillations and phase entrainment in the cerebello-thalamo-cortical network. This visit aims to evaluate the immediate effects of TUS on tremor modulation and neural activity.
  • Visit 3: Prolonged effects on Tremor Modulation This visit will evaluate the long-term effects of TUS on tremor modulation. The stimulation protocol will be extended to 30 minutes of sonication to observe whether prolonged stimulation results in stronger or sustained tremor reduction. As in Visit 2, accelerometer data will be collected to measure tremor amplitude, and EEG will be recorded to monitor changes in brain activity over the extended stimulation period. The goal is to assess the durability of the effects and refine the optimal stimulation duration.
  • Visit 4: Closed-loop Stimulation for Tremor Suppression On the fourth visit, a closed-loop stimulation protocol will be tested. This involves synchronizing the TUS delivery to either the peak or trough of the tremor oscillation to determine whether phase-specific stimulation enhances tremor modulation. Real-time tremor data will be collected using an accelerometer, and EEG will be used to track neural responses. This visit aims to explore whether closed-loop TUS can provide more precise control over tremor amplitude compared to standard on/off stimulation.

Experiment 2: Tremor Modulation in Essential Tremor Patients Building on the results from Experiment 1, 30 ET patients will participate in a similar crossover design. Patients will be recruited by a neurologist collaborating on this project. The optimized TUS parameters from Experiment 1 will be used to target the dentate nucleus. The most optimal protocol for tremor reduction will be selected during this experiment. Thus, experiment 2 will exist of one visit day for imaging and another visit day to test the most optimal TUS protocol. Similarly, tremor amplitude will be measured using an accelerometer, and EEG will monitor neural activity during stimulation.

02

Conditions studied

  • Essential Tremor

Keywords

  • transcranial focused ultrasound stimulation
  • TUS
  • Essential Tremor
  • ET
  • Movement disorders
  • Neuromodulation
  • NIBS
  • non-invasive brain stimulation
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Experiment 1: Healthy Volunteers

    1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
    2. Participants aged 18-55 years
    3. Male of female
    4. Good health with no history of serious mental illness or implanted metal
    5. Willingness to adhere to the TUS and MRI study schedule
    6. Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation
  • Experiment 2: ET Patients

    1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
    2. Participants aged 18-75 years
    3. Male of female
    4. Diagnosis of ET as confirmed from clinical history and examination by a movement disorder neurologist
    5. Willingness to adhere to the TUS and MRI study schedule
    6. Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation

Exclusion criteria

Exclusion Criteria:

  • Experiment 1: Healthy volunteers

    1. Currently taking any psychotropic medication
    2. Any head trauma resulting in loss of consciousness
    3. Diagnosed with a serious mental illness
    4. Alcohol or substance abuse or dependence (other than tobacco) in the past week
    5. Currently in treatment for a psychiatric condition
    6. Pregnancy (a test will be scheduled by the research team)
    7. Personal or family history of seizures or epilepsy
    8. Claustrophobia or inability to stay still in the MR scanner environment
    9. Any metal in the body that is not MRI-compatible
    10. Serious history of migraines
    11. Hair in dreadlocks, braids, or weave (not possible to position ultrasound transducer)
    12. orthopedic forearm or hand problems
    13. Inability to adhere to the experimental schedule.
  • Experiment 2: ET Patients

    1. Currently taking any psychotropic medication
    2. Implanted with a non-MRI compatible medical device
    3. History of thalamotomy
    4. Skin lesions at stimulation site
    5. Peripheral neuropathy
    6. neurologic exam not consistent with ET
    7. Any head trauma resulting in loss of consciousness
    8. Diagnosed with a serious mental illness
    9. Alcohol or substance abuse or dependence (other than tobacco) in the past week
    10. alcohol or caffeine consumption within 12 hours of study enrollment.
    11. Currently in treatment for a psychiatric condition
    12. Pregnancy (scheduled test)
    13. Personal or family history of seizures or epilepsy
    14. Claustrophobia or inability to stay still in the MR scanner environment
    15. Any metal in the body that is not MRI-compatible
    16. Serious history of migraines
    17. Hair in dreadlocks, braids, or weave
    18. orthopedic forearm or hand problems
    19. Inability to adhere to the experimental schedule.
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    On-target to sham

    Participants in this arm will receive on-target stimulation first, followed by the sham condition

    Device: Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox · Device: Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox

  • Experimental
    Sham to on-target

    Participants in this arm will receive sham stimulation first, followed by the on-target stimulation

    Device: Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox · Device: Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox

Interventions

  • DeviceTranscranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox

    This study will look at both physiological tremor in healthy volunteers and pathological tremor in ET patients. A set of parameters will be tested in healthy volunteers and the optimal combination of pulse repetition frequency (PRF) and pulse duration (PD) will be selected. A closed-loop system will also be tested where the timing of the ultrasound pulses is locked to the peak or the trough of the measured tremor and can adjust in real-time.

  • DeviceTranscranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox

    This condition will serve as the active control (sham stimulation).

05

What researchers measure

Primary outcomes

  1. Tremor amplitude

    Extracted from accelerometer data. The PCA component will be calculated by combining data from all three accelerometer axis (x, y and z). The power spectral density average of this PCA component will be calculated before (1min), during and after (1 min) stimulation. The primary outcome is the change in tremor amplitude (m/s²) across pre-, during-, and post-TUS conditions.

    Time frame: Experiment 1 (short-term effects): 1-minute recording segments up to 10 minutes after stimulation, Experiment 1(long-term effects): Up to 30 minutes after stimulation Experiment 2 (Essential tremor): Up to 30 minutes after stimulation

  2. Tremor frequency

    Tremor frequency will be derived from the same one-dimensional signal obtained via principal component analysis (PCA) of the triaxial accelerometer data. The power spectral density (PSD) will be estimated using Welch's method for each recording segment (pre-TUS, during TUS, post-TUS). The dominant tremor frequency will be defined as the frequency corresponding to the maximum PSD value within the predefined tremor band (e.g., 4-12 Hz) (expressed in Hz)

    Time frame: Experiment 1 (short-term effects): 1-minute recording segments up to 10 minutes after stimulation, Experiment 1 (long-term effects): Up to 30 minutes after stimulation Experiment 2 (Essential tremor): Up to 30 minutes after stimulation

Secondary outcomes

  1. EEG oscillatory activity

    Absolute and relative power change per band (post-TUS vs baseline, and vs sham/off-target). Power spectral density will be calculated and band-limited power will be extracted: Alpha (8-12 Hz), beta (13-30 Hz),Theta (4-8 Hz) and gamma (\>30 Hz).

    Time frame: Experiment 1 (short-term effects): 1-minute segments of on/off stimulation from 10 minutes before stimulation up until 10 minutes after stimulation Experiment 1 (long-term effects) & 2: 10 minutes before stimulation up until 30 minutes after stimulation

  2. EEG Phase

    EEG phase (radians) using Hilbert transform at the tremor frequency will be extracted per channel.

    Time frame: Experiment 1 (short-term): During 1-minute segments of ON-stimulation Experiment 1 (long-term): During full 30-minute stimulation session. Experiment 2 (essential tremor): During full 30-minute stimulation session.

  3. Phase-Locking Value

    Alignment of the instantaneous phase of the EEG signal to TUS pulses (PRF). range 0-1 with 0 = random phase, 1 = perfect alignment

    Time frame: Experiment 1 (short-term): During 1-minute segments of ON-stimulation Experiment 1 (long-term): During full 30-minute stimulation session. Experiment 2 (essential tremor): During full 30-minute stimulation session.

06

Study locations

1 site
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07508696
Lead sponsor
KU Leuven
Responsible party
Myles Mc Laughlin (Prof., KU Leuven) — Principal investigator
First posted
Apr 2, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Jun 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Apr 2, 2026

Study contacts

Robrecht W. Pieters, Master
Contact
robrecht.pieters@kuleuven.be
+32 470 19 39 83
Myles Mc Laughlin, Professor
Contact
myles.mclaughlin@kuleuven.be
+32 468 24 91 64

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion